DeutschNewstral
Article
The Columbian on 2015-03-15 14:00
Berko: Buy biopharmaceutical stock, but not on margin
Related news
- Berko: Never buy stock that has no sales and earningsThe Columbian
- Berko: Hold onto Sears catalogs, but don't invest in its stockThe Columbian
BERKO: Avoid Best Buy; Coke stock is the real thing mecktimes.com- Berko: Dump Shake Shack stock nowThe Columbian
- Berko: Explaining ROE, net profit marginThe Columbian
- BERKO: What to Do With GlaxoSmithKline and Geron Stockmecktimes.com
Berko: Roomba parent iRobot is growing quickly, but its stock price is already loftybizjournals.com- Berko: Tronc an excellent speculation but bad investmentThe Columbian
- Berko: Sorry, but your son is a bad investmentThe Columbian
- Berko: Broker is bonkers for urging sale of AT&T stockThe Columbian
- Longtime stock market columnist Malcolm Berko diesbizjournals.com
- TTarget sales surge 13.2% in Q3, but stock drops 4.7% on profit margin concernstwincities.com
- Berko: Sell, then buy those oil sharesThe Columbian
- BERKO: Is GoPro Stock a Go?mecktimes.com
- Berko: Newest toy won't affect Apple stockThe Columbian
- Berko: Indian stock market inspires little confidenceThe Columbian
- Berko on Nike stock: Just buy itbizjournals.com
Best Buy reports merry holiday sales, but stock slidesStar Tribune- IAmazon stock is attractive but look to buy below $100invezz.com
- MTarget stock waffles after earnings beat by wide margin but profit outlook was below forecasts2 min readmarketwatch.com